有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | N-[(1S)-1-cyclopropylethyl]-2-(4-hydroxyphenyl)sulfanylacetamide | —— | C13H17NO2S |
|
—— | 4-[[[(2S)-2-pyridin-2-ylsulfanylpropanoyl]amino]methyl]cyclohexane-1-carboxylic acid | —— | C16H22N2O3S |
|
—— | (2R)-N-(2-aminoethyl)-2-pyridin-2-ylsulfanylpropanamide | —— | C10H15N3OS |
|
—— | (2R)-2-(2-phenylsulfanylimidazo[4,5-b]pyridin-3-yl)butanoic acid | —— | C16H15N3O2S |
|
—— | 1-[(1R,8S)-4-azatricyclo[4.3.1.13,8]undecan-4-yl]-2-(1,3,4-thiadiazol-2-ylsulfanyl)ethanone | —— | C14H19N3OS2 |
|
—— | (2R)-N-(3-methoxypropyl)-2-[(5-propan-2-yloxy-1,3,4-thiadiazol-2-yl)sulfanyl]propanamide | —— | C12H21N3O3S2 |
|
—— | (2R)-N-[(2S)-pentan-2-yl]-2-[(5-propan-2-yloxy-1,3,4-thiadiazol-2-yl)sulfanyl]propanamide | —— | C13H23N3O2S2 |
|
—— | N-[(1S)-1-(2,5-dimethylfuran-3-yl)ethyl]-2-pyridin-4-ylsulfanylacetamide | —— | C15H18N2O2S |
|
—— | N-[(2R)-2-cyano-3-methylbutan-2-yl]-2-(3-methylphenyl)sulfanylacetamide | —— | C15H20N2OS |
|
—— | (2R)-2-(cyclopropylmethoxy)-N-[(1S)-1-(4-methylsulfanylphenyl)ethyl]propanamide | —— | C16H23NO2S |
|
—— | (3S,5R)-3-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanyl]-5-methyloxolan-2-one | —— | C13H15N3O3S |
|
—— | (2R)-2-methoxy-N-[4-(1,3,4-thiadiazol-2-ylsulfanyl)phenyl]propanamide | —— | C12H13N3O2S2 |
|
—— | 4-amino-2-[(3S,5R)-5-methyl-2-oxooxolan-3-yl]sulfanylpyrimidine-5-carbonitrile | —— | C10H10N4O2S |
|
—— | (2S)-2-[3-(2,2,2-trifluoroethoxy)propylsulfonyl]propanoic acid | —— | C8H13F3O5S |
|
—— | (2R)-2-[2-(3-methoxypropylamino)-2-oxoethyl]sulfonylpropanoic acid | —— | C9H17NO6S |
|
—— | (2R)-2-[2-oxo-2-[[(2R)-pentan-2-yl]amino]ethyl]sulfonylpropanoic acid | —— | C10H19NO5S |
|
—— | (2S)-2-[2-[cyclopropyl(ethyl)amino]-2-oxoethyl]sulfonylpropanoic acid | —— | C10H17NO5S |
|
—— | (3R,5R)-3-[[5-(cyclohexylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]-5-methyloxolan-2-one | —— | C13H19N3O2S2 |
|
—— | N-[[(1S)-cyclohex-3-en-1-yl]methyl]-2-pyridin-4-ylsulfanylacetamide | —— | C14H18N2OS |
|
—— | 2-[1-[(2S)-1-(ethylamino)-1-oxopropan-2-yl]tetrazol-5-yl]sulfanylacetic acid | —— | C8H13N5O3S |
|
—— | 2-[[4-[(3R)-1-ethylpiperidin-3-yl]-1,2,4-triazol-3-yl]sulfanyl]acetic acid | —— | C11H18N4O2S |
|
—— | 2-[[4-[(2R)-1-(ethylamino)-1-oxopropan-2-yl]-1,2,4-triazol-3-yl]sulfanyl]acetic acid | —— | C9H14N4O3S |
|
—— | 2-[[4-[(2S)-1-(dimethylamino)-3-methylbutan-2-yl]-1,2,4-triazol-3-yl]sulfanyl]acetic acid | —— | C11H20N4O2S |
|
—— | 2-pyridin-4-ylsulfanyl-N-[(1S)-1-thiophen-2-ylpropyl]acetamide | —— | C14H16N2OS2 |
|
—— | 2-[[4-[(2S)-1-(ethylamino)-1-oxopropan-2-yl]-1,2,4-triazol-3-yl]sulfanyl]acetic acid | —— | C9H14N4O3S |
|
—— | 2-[1-[(3R)-1-ethylpiperidin-3-yl]tetrazol-5-yl]sulfanylacetic acid | —— | C10H17N5O2S |
|
—— | 2-[[4-[(1S)-1-(5-methylfuran-2-yl)ethyl]-1,2,4-triazol-3-yl]sulfanyl]acetic acid | —— | C11H13N3O3S |
|
—— | 2-[1-[(1R)-1-(5-methylthiophen-2-yl)ethyl]tetrazol-5-yl]sulfanylacetic acid | —— | C10H12N4O2S2 |
|
—— | 2-[1-[(2R)-1-pyrrolidin-1-ylpropan-2-yl]tetrazol-5-yl]sulfanylacetic acid | —— | C10H17N5O2S |
|
—— | 1-[[(2R)-2-(2-chlorophenyl)sulfanylpropanoyl]amino]-3-ethylurea | —— | C12H16ClN3O2S |
|
—— | 2-[[4-[(1R)-1-(5-methylthiophen-2-yl)ethyl]-1,2,4-triazol-3-yl]sulfanyl]acetic acid | —— | C11H13N3O2S2 |
|
—— | N-[(1S)-1-(5-chlorothiophen-2-yl)ethyl]-2-(1,3,4-thiadiazol-2-ylsulfanyl)acetamide | —— | C10H10ClN3OS3 |
|
—— | N-[3-[(3S)-3-methylpiperidin-1-yl]propyl]-2-(1,3,4-thiadiazol-2-ylsulfanyl)acetamide | —— | C13H22N4OS2 |
|
—— | 6-[(1S)-1-(2-chlorophenyl)ethyl]sulfanyltetrazolo[1,5-b]pyridazine | —— | C12H10ClN5S |
|
—— | 6-[(1R)-1-(2-chlorophenyl)ethyl]sulfanyltetrazolo[1,5-b]pyridazine | —— | C12H10ClN5S |
|
—— | (2R)-2-(3-cyano-5-nitropyridin-2-yl)sulfanylpropanoic acid | —— | C9H7N3O4S |
|
—— | N-[(1S)-2-(2-oxopyrrolidin-1-yl)-1-phenylethyl]-2-phenylsulfanylacetamide | —— | C20H22N2O2S |
|
—— | (2S)-N-cyclopropyl-2-(1-prop-2-enyltetrazol-5-yl)sulfanylpropanamide | —— | C10H15N5OS |
|
—— | (2R)-N-[(2S)-2-hydroxy-2-phenylethyl]-2-(1,3,4-thiadiazol-2-ylsulfanyl)propanamide | —— | C13H15N3O2S2 |
|
—— | (2R)-2-(1-prop-2-enyltetrazol-5-yl)sulfanylpropanamide | —— | C7H11N5OS |
|
—— | N-[(1R)-1-cyano-1-cyclopropylethyl]-2-(1,3-thiazol-2-ylsulfanyl)acetamide | —— | C11H13N3OS2 |
|
—— | N-[(1S)-1-(3,4-dimethylphenyl)ethyl]-2-(1,3-thiazol-2-ylsulfanyl)acetamide | —— | C15H18N2OS2 |
|
—— | (2S,4S)-4-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]-3-oxo-2-[5-(trifluoromethyl)pyridin-2-yl]pentanenitrile | —— | C14H12F3N5OS |
|
—— | (2S,4R)-4-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]-3-oxo-2-[5-(trifluoromethyl)pyridin-2-yl]pentanenitrile | —— | C14H12F3N5OS |
|
—— | (2R,4S)-4-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]-3-oxo-2-[5-(trifluoromethyl)pyridin-2-yl]pentanenitrile | —— | C14H12F3N5OS |
|
—— | 2-(4-chlorophenyl)sulfanyl-N-[[(2S)-1,4-dioxan-2-yl]methyl]acetamide | —— | C13H16ClNO3S |
|
—— | N-[(1S)-1-cyano-1-cyclopropylethyl]-2-(1-prop-2-enyltetrazol-5-yl)sulfanylacetamide | —— | C12H16N6OS |
|
—— | (2R)-5-(2-fluorophenyl)sulfanyl-2-(4-methyl-1,3-thiazol-2-yl)-3-oxopentanenitrile | —— | C15H13FN2OS2 |
|
—— | (2R)-2-methyl-N-[4-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]phenyl]butanamide | —— | C15H18N2OS2 |
|
—— | (2R)-N-(1-cyanocyclohexyl)-2-(1,3-thiazol-2-ylsulfanyl)propanamide | —— | C13H17N3OS2 |
|